the rationale for cabozantinib in advanced rcc
Published 7 years ago • 332 plays • Length 5:56Download video MP4
Download video MP3
Similar videos
-
6:30
the rationale for using cabozantinib
-
0:51
dr. pal on the rationale for adding cabozantinib to atezolizumab in prostate cancer
-
0:51
dr. pal on the safety profile of cabozantinib/atezolizumab in advanced rcc
-
2:45
sequencing with cabozantinib in advanced hcc
-
0:52
dr. choueiri on the role of cabozantinib in rcc
-
2:43
cabozantinib after checkpoint inhibitors demonstrates preliminary efficacy in advanced rcc
-
0:29
dr. mckay on fda approval of frontline cabozantinib in rcc
-
1:16
dr. mcgregor on combination therapies with nivolumab, cabozantinib, and sunitinib in rcc
-
0:52
dr. pal on the rationale for the tivo-3 trial with tivozanib in advanced rcc
-
6:01
cabozantinib in rcc, cost of cancer care, sgr repeal, and more
-
1:12
cabozantinib for advanced renal cell carcinoma: the meteor and cabosun trials
-
0:41
dr. toni choueiri on cabozantinib and nivolumab combination in kidney cancer
-
5:31
newly diagnosed metastatic renal cell carcinoma
-
5:12
rationale for combination therapy in mrcc
-
6:42
the role of lenvatinib in advanced rcc
-
3:53
cabozantinib in combination with immunotherapy for advanced renal cell carcinoma
-
1:46
dr. meric-bernstam on cb-839 plus cabozantinib in rcc
-
2:05
esmo 2020 highlights on nivolumab cabozantinib as 1st line therapy for arcc: the checkmate 9er study
-
3:56
cabozantinib as immune modulatory therapy for advanced rcc